Telmisartan Tablets — Class I drug recall D-0326-2021
Terminated recall by Alembic Pharmaceuticals Limited, reported 2021-04-14, distributed nationwide. Labeling: Label-mixup
| Recall number | D-0326-2021 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Alembic Pharmaceuticals Limited, Tajpura, N/A, India |
| Recall initiated | 2021-03-17 |
| Classified | 2021-04-07 |
| Reported by FDA | 2021-04-14 |
| Terminated | 2022-12-05 |
| Distributed | Nationwide (US) |
| Quantity | 12,288 bottles |
| Reason classes | labeling |
| NDC | 62332-0087, 62332-0087-30, 62332-0087-91, 62332-0088, 62332-0088-30, 62332-0088-91, 62332-0089, 62332-0089-30, 62332-0089-91 |
| Lot numbers | 1905005661 |
| Expiration dates | 2022-03-20 |
Product
Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 38935, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807, NDC 62332-087-30
Reason for recall
Labeling: Label-mixup
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0326-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.